Plunkett Research Online: MiMedx Group Inc

MIMEDX GROUP INC (MDXG:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

MiMedx Group, Inc. is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants. These bio products are processed from human amniotic membrane and other birth tissues, as well as human skin and bone. Regenerative biomateri.....



MiMedx Group Inc
Ticker: MDXG
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 770-651-9100
Fax:
Address: 1775 West Oak Commons Court NE
Marietta, GA 30062 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Implants, Surgical, Manufacturing
ContactsDescription
David ColesCEO
Edward BorkowskiCFO/Executive VP
See More
MiMedx Group, Inc. is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants. These bio products are processed from human amniotic membrane and other birth tissues, as well as human skin and bone. Regenerative biomateri.....See More See More

Auditor: Cherry Bekaert LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
AmnioFix
EpiFix
OrthoFlo
AmnioFill
AmminoCord
EpiCord
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: